Critical Path Institute (C-Path)’s Post

#DigitalPathology is transforming the pace of drug discovery. Read our Clinical Insights paper and learn more! https://lnkd.in/eCvqPgey

The next step for DTx is determining how we go to market, and penetrate at a high level. If we enable a pathway for digital therapeutics to be categorized, regulated, approved and reimbursed smoothly, DTx will continue to accelerate, with software driven products that are easy to scale, easy to deliver to patients, and most importantly, bring real clinical and economic benefit. #DTx #digitaltherapeutics #harmonisation #regulatory #reimbursement

#startupmakingadifference! Established with a vision to improve patient outcomes through data-centric solutions, Algorics has been at the forefront of data-driven drug development, helping biopharma and medical device companies achieve cost-effective and accelerated delivery of treatments to patients worldwide. Algorics' clinical data intelligence platform, Clarity developed maximizes site, patient, and study-level insights through data analytics and visualization that helps biopharma companies effectively identify drug safety and efficacy trends as well as emerging issues early on. Read more: https://lnkd.in/gdwxiwMa #DataDrivenHealthcare #ClinicalInnovation #PatientOutcomes #BiopharmaSolutions #DrugDevelopment #DataIntelligence #ClinicalAnalytics #AcceleratedTreatmentDelivery #HealthTechInsights #AlgoricsClarity

As 2023 draws to a close, we asked which trends you think will have the biggest impact on your work in 2024. Most voters (almost 70%!) chose AI’s impact on drug discovery and clinical trials as the top predicted trend for next year. #MERITCRO #YourClinicalEndpointExpert #ArtificialIntelligence #clinicaltrials #clinicalresearch

Amidst concerns around the IRA's impact on biopharma, a visionary plan is needed to streamline early-phase trials and empower mid-market and emerging companies. 💡 Our CEO, Dr. Harsha K Rajasimha, Ph.D., shares a revolutionary approach to efficiently managing clinical trials and navigating drug pricing controls. Discover how Jeeva Clinical Trials Inc.'s tech-driven trial system cuts costs, enhances efficiency, prioritizes patients and innovation, and champions breakthrough therapies for all conditions. 🌐💊 Learn more: https://hubs.la/Q02sX4Fh0 #healthtech #clinicaltrials #emergingbiopharma #IRA #jeevatrials

Kick-off 2024 with an informative live webinar offering an in-depth look at the history and overview of the clinical trial process. On January 17, Pranali Wandile, South Carolina Clinical Research LLC. will guide you through topics like drug development, human research protection, study designs, and more. Enroll today (with or without contact hours) > https://bit.ly/41pAhFo #ACRP #ClinicalResearch #ClinicalTrials #Webinar #DrugDevelopment #StudyDesign

In #drugdevelopment, there is a critical need to innovate beyond mere computational enhancements and adopt a holistic approach that ensures the entire drug development process is geared towards achieving successful clinical outcomes. Learn how AtlasGEN Novel Drug Designer accomplishes this in our latest white paper: https://hubs.li/Q02DMjK_0

Navigate through the intricate world of drug therapy with our expert consultants. We simplify the complexities, providing you with easy-to-understand, actionable advice. #MckinneyTX #ConsultingServices #DrugTherapy 

Why have TACE outcomes remained the same for decades? Delivery method matters. Pressure-Enabled Drug Delivery™ (PEDD™) with SmartValve® technology has been shown to deliver more therapy and drive better response. Learn more: https://lnkd.in/dS6C9Dae #irad #livercancer #drugdelivery

🌟 Navigating the Patent Landscape for iPSC Derived Therapeutics 🌟 Are you developing groundbreaking iPSC-derived therapeutics? At Lindville Bio, we know that understanding patents can be complex, especially when it comes to differentiating between patentability and freedom to operate. 🔍 Imagine you've created a revolutionary iPSC-derived therapeutic and secured a patent for it. Exciting, right? But when you move forward, you might discover that your therapeutic infringes on existing patents for related technologies or methods. 💡 This underscores a critical point: patentability and freedom to operate are separate issues. Patent Offices only assess patentability, not whether you can freely use your invention without infringing others' patents. 🛠️ Ensure your path to market is clear. At www.lindvillebio.com, we work with lawyers to help you navigate these complexities and secure your therapeutic’s success. #Patents #iPSC #Therapeutics #LindvilleBio #FreedomToOperate #IntellectualProperty #PatentSearch #BiotechInnovation